Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

Clinical trial NCT06790784 · RECRUITING

Trial details

NCT number: NCT06790784
Sponsor: Jaeb Center for Health Research
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Proliferative Diabetic Retinopathy (PDR)

Start date: 2025-08-04
Primary completion: 2031-08-01
Enrollment: 426

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.